Fact CheckerSign in

NCT06541990Recruiting

Psychoeducational Intervention for Patients With Hepatocellular Carcinoma

HARMONY: A Psychoeducational Intervention to Reduce Psychological Distress and Improve Quality of Life for Patients With Hepatocellular Carcinoma

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

This study aims to refine and pilot test HARMONY, a psychoeducational intervention for patients with newly diagnosed hepatocellular carcinoma (HCC).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
3 Aug 2024
Start date
28 Oct 2024
Primary completion date
31 Mar 2027
Lead sponsor
Massachusetts General Hospital
NCT number
NCT06541990

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 28 Oct 2024 to the primary completion date, 31 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Incidentally diagnosed with HCC after liver transplantation

Other illness

  • Significant uncontrolled hepatic encephalopathy, cognitive impairment, or psychiatric disorder which will interfere with study participation

Other

  • Patients near the end of life for whom hospice is recommended

Who the study is looking for

  • Age ≥18 years
  • New diagnosis of HCC within the last six months
  • Ability to complete study procedures English

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.